Advertisement
Advertisement
IMDX
Insight Molecular Diagnostics Inc. Common Stock
4.83
USDSponsored
+0.03
+0.63%
Aug 07, 15:59 UTC -4
Closed
Pre-Market
4.83
0.00
0.00%
IMDX Earnings Reports
Positive Surprise Ratio
IMDX beat 16 of 42 last estimates.
38%
Next Report
Today AMC
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$446.25K
/-$0.24
Implied change from Q1 26 (Revenue/ EPS)
+1294.53%
/+100.00%
Implied change from Q2 25 (Revenue/ EPS)
-13.85%
/-20.00%
Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue
On May 13, 2026, IMDX reported earnings of -0.12 USD per share (EPS) for Q1 26, beating the estimate of -0.26 USD, resulting in a 55.01% surprise. Revenue reached 32.00 thousand, compared to an expected 306.00 thousand, with a -89.54% difference. The market reacted with a +25.88% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 446.25 thousand USD, implying an increase of 100.00% EPS, and increase of 1294.53% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.86
Actual
$0.90
Surprise
+3.97%
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
Evolent Health, Inc Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.02
Surprise
+183.68%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
Health Catalyst, Inc Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.02
Actual
$0.04
Surprise
+45.45%
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
Outset Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.80
Surprise
-7.87%
10x Genomics, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.14
Surprise
+43.09%
iRhythm Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.57
Surprise
+12,988.89%
Doximity, Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.31
Actual
$0.28
Surprise
-6.66%
FAQ
What were Insight Molecular Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Insight Molecular Diagnostics Inc. Common Stock reported EPS of -$0.12, beating estimates by 55.01%, and revenue of $32.00K, -89.54% below expectations.
How did the market react to Insight Molecular Diagnostics Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 25.88%, changed from $5.10 before the earnings release to $6.42 the day after.
When is Insight Molecular Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Insight Molecular Diagnostics Inc. Common Stock's next earnings report?
Based on 5
analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $446.25K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement